Patients and advocates are now calling for greater awareness of the EU-mandated Treatment Abroad Scheme, and a streamlined ...

The narcolepsy treatment market is projected to grow from USD 5,301.6 million in 2024 to USD 8,718.3 million by 2034, at a ...

The largest and most diverse genetic study of depression has identified 300 new genetic risk factors for the condition across ...

Neumirna Therapeutics has raised €20m to develop microRNA therapies for epilepsy and other neurological conditions.